{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:38:24Z","timestamp":1792849104006,"version":"4.5.0"},"reference-count":24,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00220894"],"award-info":[{"award-number":["RS-2023-00220894"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Selective Nav1.7 inhibition is a genetically validated, non-opioid strategy for chronic neuropathic pain. Herein, we report the structure-guided discovery of a quinazoline-based Nav1.7 inhibitor series. From a focused-library hit A1 (IC50 = 15.2 \u03bcM), systematic SAR across 19 analogs yielded the chiral lead (R)-(+)-A11 (IC50 = 0.98 \u03bcM; 53.9-fold selectivity over Nav1.5), with absolute configuration confirmed by MicroED (Flack x = 0.03(12)). (R)-(+)-A11 displayed favorable oral pharmacokinetics (F = 28.2%, free Cmax = 1.06 \u03bcM) and dose-dependent analgesia in mouse formalin (ED50 = 18.5 mg\/kg) and rat CCI (83% MPE; ED50 = 17.1 mg\/kg) models. Off-target profiling of A11 (racemate) against 44 targets showed &amp;lt;10% inhibition at 10 \u03bcM, and DRG CGRP target engagement by (R)-(+)-A11 (IC50 = 0.42 \u03bcM), with Nav1.7-KO neuron controls supporting Nav1.7 as the primary mechanism. These results establish (R)-(+)-A11 as a promising quinazoline lead for non-opioid neuropathic pain therapeutics.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c02422","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:02:28Z","timestamp":1790794948000},"page":"24748-24766","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of a Quinazoline-Based Nav1.7 Inhibitor with MicroED-Confirmed Absolute Configuration and Oral Efficacy in Rodent Models of Neuropathic Pain"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-6521","authenticated-orcid":true,"given":"Jae Ho","family":"Shim","sequence":"first","affiliation":[{"name":"Korea University College of Medicine , , 73 Inchon-ro Seongbuk-gu , ,","place":["Seoul, Republic of Korea, 02841"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooreum","family":"Lim","sequence":"additional","affiliation":[{"name":"Korea University College of Medicine , , 73 Inchon-ro Seongbuk-gu , ,","place":["Seoul, Republic of Korea, 02841"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwoo","family":"Woo","sequence":"additional","affiliation":[{"name":"Korea University College of Medicine , , 73 Inchon-ro Seongbuk-gu , ,","place":["Seoul, Republic of Korea, 02841"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Han","sequence":"additional","affiliation":[{"name":"Korea University College of Medicine , , 73 Inchon-ro Seongbuk-gu , ,","place":["Seoul, Republic of Korea, 02841"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Korea University College of Medicine , , 73 Inchon-ro Seongbuk-gu , ,","place":["Seoul, Republic of Korea, 02841"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026102408070304800_cit1","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic Pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2026102408070304800_cit2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jvs.2015.08.010","article-title":"Pharmacotherapy for Neuropathic Pain in Adults: a Systematic Review and Meta-analysis","volume":"62","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"2026102408070304800_cit3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A Channelopathy Causes Congenital Inability to Experience Pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"2026102408070304800_cit4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, Encoding a Sodium Channel Alpha Subunit, in Patients with Primary Erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J. Med. Genet."},{"key":"2026102408070304800_cit5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Gating Defects and Developmental Expression Patterns","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"key":"2026102408070304800_cit6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn3404","article-title":"The Nav1.7 Sodium Channel: From Molecule to Man","volume":"14","author":"Dib-Hajj","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"2026102408070304800_cit7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The Role of Voltage-Gated Sodium Channels in Pain Signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol. Rev."},{"key":"2026102408070304800_cit8","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1073\/pnas.96.14.7635","article-title":"Sodium Channels and Pain","volume":"96","author":"Waxman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026102408070304800_cit9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"The Roles of Sodium Channels in Nociception: Implications for Mechanisms of Pain","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"key":"2026102408070304800_cit10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","article-title":"Nav1.7 and Other Voltage-Gated Sodium Channels as Drug Targets for Pain Relief","volume":"20","author":"Emery","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"2026102408070304800_cit11","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1021\/acs.jmedchem.7b00598","article-title":"Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7","volume":"60","author":"Swain","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026102408070304800_cit12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/mol.116.105437","article-title":"The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels","volume":"90","author":"Theile","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"2026102408070304800_cit13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau2486","article-title":"Structure of the Human Voltage-Gated Sodium Channel Nav1.4 in Complex with \u03b21","volume":"362","author":"Pan","year":"2018","journal-title":"Science"},{"key":"2026102408070304800_cit14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/d41573-024-00203-3","article-title":"NaV1.8 Inhibitor Poised to Provide Opioid-Free Pain Relief","volume":"24","author":"Kingwell","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102408070304800_cit15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152405","article-title":"Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis","volume":"11","author":"Alexandrou","year":"2016","journal-title":"PLoS One"},{"key":"2026102408070304800_cit16","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1021\/acs.jmedchem.1c00049","article-title":"Discovery of Acyl-Sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310","volume":"64","author":"Safina","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026102408070304800_cit17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Irreversible Inhibitor Design","volume":"11","author":"Yun","year":"2007","journal-title":"Cancer Cell"},{"key":"2026102408070304800_cit18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0163-7258(98)00044-8","article-title":"Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors","volume":"82","author":"Traxler","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"2026102408070304800_cit19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2019.11.041","article-title":"Structure of the Cardiac Sodium Channel","volume":"180","author":"Jiang","year":"2020","journal-title":"Cell"},{"key":"2026102408070304800_cit20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s1474-4422(17)30005-4","article-title":"Safety and Efficacy of a Nav1.7 Selective Sodium Channel Blocker in Patients with Trigeminal Neuralgia: A Double-Blind, Mechanistic, Translational, Randomised Clinical Trial","volume":"16","author":"Zakrzewska","year":"2017","journal-title":"Lancet Neurol."},{"key":"2026102408070304800_cit21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nrd.2017.91","article-title":"Opportunities for Therapeutic Antibodies Directed at G-Protein-Coupled Receptors","volume":"16","author":"Hutchings","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102408070304800_cit22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A Comprehensive Map of Molecular Drug Targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102408070304800_cit23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods Used to Evaluate Pain Behaviors in Rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"2026102408070304800_cit24","doi-asserted-by":"publisher","first-page":"E2724","DOI":"10.1073\/pnas.1220844110","article-title":"Voltage Sensor Interaction Site for Selective Small Molecule Inhibitors of Voltage-Gated Sodium Channels","volume":"110","author":"McCormack","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c02422","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24748\/68716285\/jm6c02422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/24748\/68716285\/jm6c02422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:23:35Z","timestamp":1792848215000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/24748\/5442677\/Discovery-of-a-Quinazoline-Based-Nav1-7-Inhibitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":24,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02422","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}